Polypeptide targeting LRG1 protein and application thereof

The invention provides a polypeptide targeting LRG1 protein, and belongs to the technical field of biological medicines, and the amino acid sequence of the polypeptide is as shown in SEQ ID NO.1. The polypeptide can specifically target tumor cells or tumor tissues, so that the polypeptide and the derivative thereof have important application value in early diagnosis, screening and targeted therapy of breast cancer. The invention also provides an application of the polypeptide targeting the LRG1 protein in preparation of a cancer diagnostic reagent..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 17. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

QI YINGQIU [VerfasserIn]
CHEN MENGDIE [VerfasserIn]
YANG QIAN [VerfasserIn]
ZHANG XIAOYU [VerfasserIn]
ZHANG LIJING [VerfasserIn]
MIN HUAN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che
G01N: Investigating or analysing materials by determining (...)
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-17, Last update posted on www.tib.eu: 2024-02-05, Last updated: 2024-02-09

Patentnummer:

CN117069802

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA019100388